|
EP400 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.422300E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.996600E-03 |
| Normal-vs-Stage2 |
1.790200E-01 |
| Normal-vs-Stage3 |
1.227450E-01 |
| Normal-vs-Stage4 |
4.469000E-01 |
| Stage1-vs-Stage2 |
9.781600E-01 |
| Stage1-vs-Stage3 |
9.168000E-01 |
| Stage1-vs-Stage4 |
5.615200E-01 |
| Stage2-vs-Stage3 |
9.581000E-01 |
| Stage2-vs-Stage4 |
6.199200E-01 |
| Stage3-vs-Stage4 |
6.236600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.257280E-03 |
| Normal-vs-AfricanAmerican |
1.195640E-02 |
| Normal-vs-Asian |
4.179600E-01 |
| Caucasian-vs-AfricanAmerican |
9.115200E-01 |
| Caucasian-vs-Asian |
6.568000E-01 |
| AfricanAmerican-vs-Asian |
6.261000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.460500E-03 |
| Normal-vs-Female |
3.643200E-04 |
| Male-vs-Female |
1.199640E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.939900E-02 |
| Normal-vs-Extreme_Weight |
7.335500E-02 |
| Normal-vs-Obese |
1.836790E-03 |
| Normal-vs-Extreme_Obese |
6.439400E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.899000E-01 |
| Normal_Weight-vs-Obese |
2.123600E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.182800E-01 |
| Extreme_Weight-vs-Obese |
1.694970E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.846800E-01 |
| Obese-vs-Extreme_Obese |
6.908100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.639500E-04 |
| Normal-vs-Age(41-60Yrs) |
6.13760000000019E-05 |
| Normal-vs-Age(61-80Yrs) |
3.851600E-02 |
| Normal-vs-Age(81-100Yrs) |
9.397200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.768020E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.565900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.369750E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.747900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.565500E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.445200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.40410000004643E-06 |
| Normal-VS-Type2 PRCC |
1.852780E-01 |
| Normal-VS-KIRP CIMP |
1.162970E-01 |
| Normal-VS-Unclassified PRCC |
3.037500E-03 |
| Type1 PRCC-VS-Type2 PRCC |
1.41540001941109E-09 |
| Type1 PRCC-VS-KIRP CIMP |
8.341400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
7.949600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.167570E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
2.619400E-04 |
| KIRP CIMP-VS-Unclassified PRCC |
7.613000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.000800E-01 |
| Normal-vs-N1 |
2.091600E-02 |
| Normal-vs-N2 |
1.319410E-01 |
| N0-vs-N1 |
4.582000E-02 |
| N0-vs-N2 |
4.339400E-01 |
| N1-vs-N2 |
7.024800E-01 |
|
|
